TOP2B and cardiomyopathy: DEX, in addition to its iron ion chelation, affects Top2β, preventing the inhibition of this enzyme by DOX in cardiomyocytes, which results in a cytoprotective effect, decreasing the incidences of cardiomyopathy and congestive heart failure [31,32,33].